nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Ototoxicity—Tretinoin—peripheral nervous system neoplasm	0.0699	0.0699	CcSEcCtD
Neomycin—Ototoxicity—Isotretinoin—peripheral nervous system neoplasm	0.0699	0.0699	CcSEcCtD
Neomycin—Ototoxicity—Alitretinoin—peripheral nervous system neoplasm	0.053	0.053	CcSEcCtD
Neomycin—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0478	0.0478	CcSEcCtD
Neomycin—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0478	0.0478	CcSEcCtD
Neomycin—Ototoxicity—Cisplatin—peripheral nervous system neoplasm	0.0452	0.0452	CcSEcCtD
Neomycin—Sensitisation—Isotretinoin—peripheral nervous system neoplasm	0.0393	0.0393	CcSEcCtD
Neomycin—Sensitisation—Tretinoin—peripheral nervous system neoplasm	0.0393	0.0393	CcSEcCtD
Neomycin—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0362	0.0362	CcSEcCtD
Neomycin—Impaired healing—Tretinoin—peripheral nervous system neoplasm	0.0325	0.0325	CcSEcCtD
Neomycin—Impaired healing—Isotretinoin—peripheral nervous system neoplasm	0.0325	0.0325	CcSEcCtD
Neomycin—Impaired healing—Melphalan—peripheral nervous system neoplasm	0.032	0.032	CcSEcCtD
Neomycin—Sensitisation—Alitretinoin—peripheral nervous system neoplasm	0.0298	0.0298	CcSEcCtD
Neomycin—Nephrotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0285	0.0285	CcSEcCtD
Neomycin—Impaired healing—Alitretinoin—peripheral nervous system neoplasm	0.0246	0.0246	CcSEcCtD
Neomycin—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.0158	0.0158	CcSEcCtD
Neomycin—Nephropathy toxic—Cisplatin—peripheral nervous system neoplasm	0.0158	0.0158	CcSEcCtD
Neomycin—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Neomycin—Nephropathy toxic—Etoposide—peripheral nervous system neoplasm	0.0145	0.0145	CcSEcCtD
Neomycin—Sensitisation—Epirubicin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Neomycin—Sensitisation—Doxorubicin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Neomycin—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Neomycin—Swelling—Tretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Neomycin—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00875	0.00875	CcSEcCtD
Neomycin—Swelling—Etoposide—peripheral nervous system neoplasm	0.00683	0.00683	CcSEcCtD
Neomycin—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00614	0.00614	CcSEcCtD
Neomycin—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00614	0.00614	CcSEcCtD
Neomycin—Viral infection—Epirubicin—peripheral nervous system neoplasm	0.00515	0.00515	CcSEcCtD
Neomycin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Neomycin—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00502	0.00502	CcSEcCtD
Neomycin—Infection—Topotecan—peripheral nervous system neoplasm	0.00502	0.00502	CcSEcCtD
Neomycin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Neomycin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Neomycin—Infection—Tretinoin—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Neomycin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Neomycin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00494	0.00494	CcSEcCtD
Neomycin—Infection—Melphalan—peripheral nervous system neoplasm	0.00491	0.00491	CcSEcCtD
Neomycin—Viral infection—Doxorubicin—peripheral nervous system neoplasm	0.00477	0.00477	CcSEcCtD
Neomycin—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Neomycin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Neomycin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Neomycin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Neomycin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Neomycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Neomycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00369	0.00369	CcSEcCtD
Neomycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00369	0.00369	CcSEcCtD
Neomycin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Neomycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Neomycin—Infection—Vincristine—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Neomycin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Neomycin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Neomycin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Neomycin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Neomycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Neomycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Neomycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Neomycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Neomycin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Neomycin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Neomycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Neomycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Neomycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Neomycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Neomycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Neomycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Neomycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Neomycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Neomycin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Neomycin—Infection—Etoposide—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Neomycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Neomycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Neomycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Neomycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Neomycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Neomycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Neomycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Neomycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Neomycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Neomycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Neomycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Neomycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Neomycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Neomycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Neomycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Neomycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Neomycin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Neomycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Neomycin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Neomycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Neomycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Neomycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Neomycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Neomycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Neomycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Neomycin—Infection—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Neomycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Neomycin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Neomycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Neomycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Neomycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Neomycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Neomycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Neomycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Neomycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Neomycin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000986	0.000986	CcSEcCtD
Neomycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Neomycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
